<?xml version="1.0" encoding="UTF-8"?>
<app-group>
 <app id="app1-vaccines-08-00115">
  <title>Supplementary Materials</title>
  <p>The following are available online at 
   <uri xlink:href="https://www.mdpi.com/2076-393X/8/1/115/s1" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.mdpi.com/2076-393X/8/1/115/s1</uri>, Figure S1. Cells from swine muscle explants support BoHV-4 transduction and replication; Figure S2. Design and expression of Nipah virus glycoprotein F; Figure S3. Design and expression of Nipah virus glycoprotein G; Figure S4. BoHV-4 adaptation and replication in PECs; Figure S5. PECs are permissive for BoHV-1 and BVDV; Figure S6. Pig serum reduces PECs growth; Figure S7. Flow chart of the strategy used to produce BoHV-4-A-CMV-NiV-FΔTK and BoHV-4-A-CMV-NiV-GΔTK free of bovine antigens; Figure S8. Evaluation of post-vaccinal reactions of immunized pigs and assessment of BoHV-4 vector shedding; Figure S9. Evaluation of gating strategies for ICS analysis of NiV-specific CD8 T cell responses; Figure S10. Flow cytometric gating for ICS analysis of longitudinal PBMC datasets.
  </p>
 </app>
</app-group>
